等待开盘 04-02 09:30:00 美东时间
+0.040
+4.48%
今日重点评级关注:Oppenheimer:维持Alumis"跑赢大市"评级,目标价从50美元升至55美元;美银证券:维持Rocket Pharmaceuticals"买入"评级,目标价从8美元升至9美元
03-31 16:30
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
Rockwell Medical Q4 sales fall on customer volume reduction Overview U.S. hemodialysis products maker's Q4 net sales declined yr/yr due to reduced customer volume Company's Q4 gross margin rose to 21%, marking one of its strongest quarters Adjusted EBITDA was positive for Q4 and full-year, achieved
03-26 18:12
GUIDANCEFor the third year in a row, Rockwell Medical's annual performance was directly in line with its annual guidance. In 2025, Rockwell Medical's achieved net sales, gross margin and Adjusted EBITDA as
03-26 18:08
Rockwell Medical FY2025 net loss widens to $5.3 million; net sales drop 31.72% to $69.3 million Rockwell Medical published a press release reporting fourth-quarter and full-year 2025 financial and operational results. Q4 net sales fell 25.9% to USD 18.3 million, driven by reduced purchase volume fro
03-26 18:02
BRIEF-Rockwell Medical Q4 EPS USD -0.01 Mar 26 (Reuters) - Rockwell Medical Q4 gross profit USD 3.9 million. Q4 net income USD -600 thousand
03-26 18:00
Rockwell Medical (RMTI) is scheduled to announce Q4 earnings results on Thursday, March 26th, before market open. The consensus EPS Estimate is $0.02 (-50.0% Y/Y) and the consensus Revenue Estimate is...
03-26 03:24
Gainers Zevra Therapeutics (NASDAQ:ZVRA) stock moved upwards by 20.6% to $11.0...
03-10 05:05
Rockwell Medical Inc. to Release Fourth-Quarter and Full-Year Results and Host Webcast Rockwell Medical Inc. said it will release its fourth quarter and full-year 2025 financial and operational results on Thursday, March 26, 2026, via a press release at 6:00am ET, followed by a live webcast at 8:00a
02-26 19:01
今日重点评级关注:Oppenheimer:维持Pelthos Therapeutics"跑赢大市"评级,目标价从57美元升至60美元;Small Cap Consumer Research:维持Lands' End"买入"评级,目标价从20美元升至45美元
01-27 10:02